Tiny device could fix leaky heart valves without cutting chest open

NCT ID NCT07671820

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early trial tests a new device called Anchord that repairs leaky mitral valves without open-heart surgery. It will include 5 people with severe valve leakage who are too high-risk for standard surgery. The goal is to see if the device is safe and can reduce the leak, improving symptoms like shortness of breath.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Anchord Mitral Chordal Repair device

What this could lead to

If it works, this could offer a less invasive option for people with leaky heart valves who are too high-risk for open-heart surgery.

What could go wrong

This is a very early first-in-human trial with only 5 participants, so results may not apply broadly. The device could fail to reduce the leak or cause complications like infection or device movement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mitral valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••